Enjaymo 1100 mg/22 ml

Enjaymo 1100 mg/22 ml is a medicine authorised by Swissmedic under authorisation number 68074. The authorisation holder is RECORDATI AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 June 2023 and the authorisation is limited until 20 June 2028. ATC code L04AJ04 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 68074
  • ATC L04AJ04
  • Biotechnological medicines
Authorisation data
Authorisation number68074
NameEnjaymo 1100 mg/22 ml
Full nameEnjaymo 1100 mg/22 ml, Infusionslösung
Authorisation holderRECORDATI AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AJ04
First authorisation21 June 2023
Authorisation validity20 June 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Enjaymo 1100 mg/22 ml, InfusionslösungA21 June 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11 x 22 mlDurchstechflasche(n)L04AJ0407.15.0.A
26 x 22 mlDurchstechflasche(n)L04AJ0407.15.0.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Enjaymo 1100 mg/22 ml authorised in Switzerland?

Yes. Enjaymo 1100 mg/22 ml is authorised by Swissmedic under authorisation number 68074, data as of 01 September 2026. The authorisation is limited until 20 June 2028.

Which dispensing category does Enjaymo 1100 mg/22 ml have?

Enjaymo 1100 mg/22 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Enjaymo 1100 mg/22 ml?

The authorisation holder is RECORDATI AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com